PharmDr. Martin Čulen, Ph.D.

Assistant professor, Department of Internal Medicine, Hematology and Oncology

Correspondence Address:
Jihlavská 340/20, 625 00 Brno

Office: bldg. F01B2/156
Kamenice 126/3
625 00 Brno

Phone:	+420 532 23 4641
E‑mail:

social and academic networks:

Basic information

Supervision

Qualifications

Publications

Type

Total number of publications: 61

2023

Acute myeloid leukemia suppression by palbociclib and ponatinib in patient-derived xenograft.

BUŠA Daniel ČULEN Martin LOJA Tomáš JEŽÍŠKOVÁ Ivana FOLTA Alois MAYER Jiří

Conference abstract

Year: 2023, type: Conference abstract
AML engraftment in humanized ossicles is not governed by biomaterial selection.

ČULEN Martin BUŠA Daniel HERUDKOVÁ Zdeňka HÝL Jan VLAŽNÝ Jakub MATULOVÁ Květoslava REPKO Martin VOJTOVÁ Lucy MAYER Jiří

Conference abstract

Year: 2023, type: Conference abstract
Biomaterial selection does not affect AML engraftment in humanized ossicles.

ČULEN Martin LOJA Tomáš BUŠA Daniel HERUDKOVÁ Zdeňka HÝL Jan VLAŽNÝ Jakub LIŠKOVÁ K. REPKO Martin VOJTOVÁ Lucy MAYER Jiří

Conference abstract

Year: 2023, type: Conference abstract
Effect of media components and feeder cells on in vitro culture of acute myeloid leukemia.

HÝL Jan BUČKOVÁ Veronika SLAMĚNÍKOVÁ Tereza ČULEN Martin

Conference abstract

Year: 2023, type: Conference abstract
Inhibition of acute myeloid leukemia using palbociclib and ponatinib in a patient-derived xenograft model.

BUŠA Daniel ČULEN Martin LOJA Tomáš JEŽÍŠKOVÁ Ivana FOLTA Adam MAYER Jiří

Conference abstract

Year: 2023, type: Conference abstract
Povrchové markery leukemických kmenových buněk u chronické myeloidní leukemie

SMITALOVÁ Dagmar JEŽÍŠKOVÁ Ivana MAYER Jiří ŽÁČKOVÁ Daniela ČULEN Martin

Article in Periodical

Transfuze a hematologie dnes, year: 2023, volume: 29, edition: 1, DOI

2022

. Drug repurposing for venetoclax-resistant acute myeloid leukemia.

LADUNGOVÁ Adriana BUŠA Daniel LODHI Yusuf HÝL Jan ČULEN Martin ŠMÍDA Michal

Conference abstract

Year: 2022, type: Conference abstract
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia

PETER Barbara EISENWORT Gregor SADOVNIK Irina BAUER Karin WILLMANN Michael RUELICKE Thomas BERGER Daniela STEFANZL Gabriele GREINER Georg HOERMANN Gregor KELLER Alexandra WOLF Dominik ČULEN Martin WINTER Georg E HOFFMANN Thomas SCHIEFER Ana-Iris SPERR Wolfgang R ZUBER Johannes MAYER Jiří VALENT Peter

Article in Periodical

American Journal of Hematology, year: 2022, volume: 97, edition: 9, DOI
Genome-wide Screening Optimizations and High-throughput Compound Screening to Identify Novel Treatment Options in Venetoclax-resistant AML

LODHI Yusuf LADUNGOVÁ Adriana BUŠA Daniel PESCHELOVÁ Helena ČULEN Martin ŠMÍDA Michal

Conference abstract

Year: 2022, type: Conference abstract
Identification of novel therapeutic options for venetoclax-resistant AML cells through drug repurposing

LADUNGOVÁ Adriana BUŠA Daniel LODHI Yusuf HÝL Jan ČULEN Martin ŠMÍDA Michal

Conference abstract

Year: 2022, type: Conference abstract

Projects

Teaching